These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 19584150)
1. Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer. Baba Y; Nosho K; Shima K; Freed E; Irahara N; Philips J; Meyerhardt JA; Hornick JL; Shivdasani RA; Fuchs CS; Ogino S Clin Cancer Res; 2009 Jul; 15(14):4665-73. PubMed ID: 19584150 [TBL] [Abstract][Full Text] [Related]
2. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency. Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features. Zlobec I; Bihl M; Foerster A; Rufle A; Lugli A J Pathol; 2011 Nov; 225(3):336-43. PubMed ID: 21660972 [TBL] [Abstract][Full Text] [Related]
4. CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival. Firestein R; Shima K; Nosho K; Irahara N; Baba Y; Bojarski E; Giovannucci EL; Hahn WC; Fuchs CS; Ogino S Int J Cancer; 2010 Jun; 126(12):2863-73. PubMed ID: 19790197 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer. Ogino S; Kawasaki T; Kirkner GJ; Ogawa A; Dorfman I; Loda M; Fuchs CS J Pathol; 2006 Oct; 210(2):147-54. PubMed ID: 16850502 [TBL] [Abstract][Full Text] [Related]
6. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer. Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523 [TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer. Kure S; Nosho K; Baba Y; Irahara N; Shima K; Ng K; Meyerhardt JA; Giovannucci EL; Fuchs CS; Ogino S Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2765-72. PubMed ID: 19789368 [TBL] [Abstract][Full Text] [Related]
8. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer. Nosho K; Shima K; Irahara N; Kure S; Baba Y; Kirkner GJ; Chen L; Gokhale S; Hazra A; Spiegelman D; Giovannucci EL; Jaenisch R; Fuchs CS; Ogino S Clin Cancer Res; 2009 Jun; 15(11):3663-71. PubMed ID: 19470733 [TBL] [Abstract][Full Text] [Related]
9. SMO expression in colorectal cancer: associations with clinical, pathological, and molecular features. Li T; Liao X; Lochhead P; Morikawa T; Yamauchi M; Nishihara R; Inamura K; Kim SA; Mima K; Sukawa Y; Kuchiba A; Imamura Y; Baba Y; Shima K; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S; Qian ZR Ann Surg Oncol; 2014 Dec; 21(13):4164-73. PubMed ID: 25023548 [TBL] [Abstract][Full Text] [Related]
10. PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype. Baba Y; Nosho K; Shima K; Goessling W; Chan AT; Ng K; Chan JA; Giovannucci EL; Fuchs CS; Ogino S Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):822-31. PubMed ID: 20200425 [TBL] [Abstract][Full Text] [Related]
11. Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer. Kim JH; Kang GH World J Gastroenterol; 2014 Apr; 20(15):4230-43. PubMed ID: 24764661 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. Nosho K; Irahara N; Shima K; Kure S; Kirkner GJ; Schernhammer ES; Hazra A; Hunter DJ; Quackenbush J; Spiegelman D; Giovannucci EL; Fuchs CS; Ogino S PLoS One; 2008; 3(11):e3698. PubMed ID: 19002263 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers. Ogino S; Nosho K; Irahara N; Shima K; Baba Y; Kirkner GJ; Meyerhardt JA; Fuchs CS J Clin Oncol; 2009 Sep; 27(27):4591-8. PubMed ID: 19704056 [TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype. Nosho K; Kawasaki T; Chan AT; Ohnishi M; Suemoto Y; Kirkner GJ; Fuchs CS; Ogino S Histopathology; 2008 Nov; 53(5):588-98. PubMed ID: 18983468 [TBL] [Abstract][Full Text] [Related]
15. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients. Bae JM; Lee TH; Cho NY; Kim TY; Kang GH World J Gastroenterol; 2015 Feb; 21(5):1457-67. PubMed ID: 25663765 [TBL] [Abstract][Full Text] [Related]
16. Aurora-A expression is independently associated with chromosomal instability in colorectal cancer. Baba Y; Nosho K; Shima K; Irahara N; Kure S; Toyoda S; Kirkner GJ; Goel A; Fuchs CS; Ogino S Neoplasia; 2009 May; 11(5):418-25. PubMed ID: 19412426 [TBL] [Abstract][Full Text] [Related]
17. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. Walsh MD; Clendenning M; Williamson E; Pearson SA; Walters RJ; Nagler B; Packenas D; Win AK; Hopper JL; Jenkins MA; Haydon AM; Rosty C; English DR; Giles GG; McGuckin MA; Young JP; Buchanan DD Mod Pathol; 2013 Dec; 26(12):1642-56. PubMed ID: 23807779 [TBL] [Abstract][Full Text] [Related]
18. Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP. Ogino S; Kawasaki T; Kirkner GJ; Yamaji T; Loda M; Fuchs CS Mod Pathol; 2007 Jan; 20(1):15-22. PubMed ID: 17086168 [TBL] [Abstract][Full Text] [Related]
19. JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype. Nosho K; Shima K; Kure S; Irahara N; Baba Y; Chen L; Kirkner GJ; Fuchs CS; Ogino S Neoplasia; 2009 Jan; 11(1):87-95. PubMed ID: 19107235 [TBL] [Abstract][Full Text] [Related]
20. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels. Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]